NCT00522431View on ClinicalTrials.gov

A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone

PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Hypogonadism
Interventions
DRUG

Testosterone

2% gel

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY